Authors: KERSTEN MJ LANGE R SMEETS MEP VREUGDENHIL G ROOZENDAAL KJ LAMEIJER W GOUDSMIT R

Citation: Mj. Kersten et al., LONG-TERM TREATMENT OF TRANSFUSIONAL IRON OVERLOAD WITH THE ORAL IRONCHELATOR DEFERIPRONE (L1) - A DUTCH MULTICENTER TRIAL, Annals of hematology, 73(5), 1996, pp. 247-252

Authors: HOLLAK CEM GOUDSMIT R VANOERS MHJ

Citation: Cem. Hollak et al., LOW-DOSE VERSUS HIGH-FREQUENCY REGIMENS IN GAUCHERS-DISEASE, Lancet, 347(8998), 1996, pp. 406-407

Authors: HOLLAK CEM AERTS JMFG GOUDSMIT R PHOA SSKS EK M VANWEELY S VONDEMBORNE AEGK VANOERS MHJ

Citation: Cem. Hollak et al., INDIVIDUALIZED LOW-DOSE ALGLUCERASE THERAPY FOR TYPE-1 GAUCHERS-DISEASE, Lancet, 345(8963), 1995, pp. 1474-1478

Authors: GERHARTZ HH MARCUS R DELMER A ZWIERZINA H SUCIU S DARDENNE M SOLBU G DEWITTE T JACOBS A VISANI G FIERE D SONNEVELD P LABAR B HOFFBRAND AV FENAUX P HAYAT M THYSS A DEBUSSCHER L COIFFIER B SIZOO W WILLEMZE R RIBEIRO M MANDELLI F BURGHOUTS G CAUCHIE C PEETERMANS M ROOZENDAAL KJ GOUDSMIT R DOUER D CASTOLDI GL STERN A ZITTOUN R

Citation: Hh. Gerhartz et al., A RANDOMIZED PHASE-II STUDY OF LOW-DOSE CYTOSINE-ARABINOSIDE (LD-ARAC) PLUS GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (RHGM-CSF) IN MYELODYSPLASTIC SYNDROMES (MDS) WITH A HIGH-RISK OF DEVELOPING LEUKEMIA, Leukemia, 8(1), 1994, pp. 16-23

Authors: HOLLAK CEM AERTS JMFG VANWEELY S PHOA SSKS GOUDSMIT R VONDEMBORNE AEGK VANOERS MHJ

Citation: Cem. Hollak et al., ENZYME SUPPLETION THERAPY FOR TYPE-1 GAUCHER DISEASE - EFFICACY OF VERY-LOW DOSE ALGLUCERASE IN 12 PATIENTS, Blood, 82(10), 1993, pp. 10000033-10000033